Cargando…
Effectiveness of Convalescent Plasma Therapy in Severe or Critically Ill COVID-19 Patients: A Retrospective Cohort Study
PURPOSE: Coronavirus disease-2019 (COVID-19) is a novel respiratory infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); there are few specific treatments. Convalescent plasma (CP), donated by people who have recovered from COVID-19, is an investigational therap...
Autores principales: | Cho, YunSuk, Sohn, YuJin, Hyun, JongHoon, Baek, YaeJee, Kim, MooHyun, Kim, JungHo, Ahn, JinYoung, Jeong, SuJin, Ku, NamSu, Yeom, Joon-Sup, Ahn, MiYoung, Oh, DongHyun, Choi, JaePhil, Kim, SinYoung, Lee, KyoungHwa, Song, YoungGoo, Choi, JunYong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Yonsei University College of Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382726/ https://www.ncbi.nlm.nih.gov/pubmed/34427065 http://dx.doi.org/10.3349/ymj.2021.62.9.799 |
Ejemplares similares
-
Association of vancomycin trough concentration on the treatment outcome of patients with bacteremia caused by Enterococcus species
por: Sohn, Yujin, et al.
Publicado: (2021) -
Use of Convalescent Plasma Therapy in Two COVID-19 Patients with Acute Respiratory Distress Syndrome in Korea
por: Ahn, Jin Young, et al.
Publicado: (2020) -
Effects of early corticosteroid use in patients with severe coronavirus disease 2019
por: Hyun, Jong Hoon, et al.
Publicado: (2021) -
1397. Risk Factors of Unfavorable Clinical Outcomes in Patients with Brain Abscess and Subdural Empyema in Korea
por: Cho, Yunsuk, et al.
Publicado: (2019) -
Assessing Viral Shedding and Infectivity of Asymptomatic or Mildly Symptomatic Patients with COVID-19 in a Later Phase
por: Sohn, Yujin, et al.
Publicado: (2020)